mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-12 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
7e-12 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-10 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-10 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-09 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
2e-09 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-09 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-09 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
9e-09 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-08 |